Language

Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.   

Select Language

Great News for Arlington, VA: Virginia Cancer Specialists Opens New, Expanded Cancer Center, Now Open

Virginia Cancer Specialists Ballston office building exterior

A state-of-the-art cancer center, Virginia Cancer Specialists, relocates its Arlington practice to a new expanded clinical and research facility to better serve patients throughout Northern Virginia. The new 17,000 square foot Arlington, VA, cancer center is Virginia Cancer Specialists’ fourth expansion in the last 6 months, with additional expansions planned throughout 2024.   ARLINGTON, Va., […]

Dr. Mitul Gandhi, Medical Oncologist at Virginia Cancer Specialists, Co-Authors Real-World Study Assessing Efficacy of Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndromes

Cancer in the blood outbreak and treatment for malignant cells in a human body caused by carcinogens and genetics with a cancerous cell as an immun...

Dr. Mitul Gandhi, Medical Oncologist at Virginia Cancer Specialists, Co-Authors Real-World Study Assessing Efficacy of Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndromes This study highlights the need for new therapies that improve complete remission and survival rates in patients with HR-MDS. Fairfax, Virginia, February 9, 2024 – Virginia Cancer Specialists, a premier provider of […]

Landmark Non-Small Cell Lung Cancer Study – Clinically Meaningful Improvement and Progression Free Survival, Alexander I. Spira, MD, PhD, FACP 

Lung cancer on blue background, 3D illustration

Virginia Cancer Specialists Research Institute – Landmark “Non-Small Cell Lung Cancer Study” – Alexander I. Spira, MD, PhD, FACP  Planned interim overall survival analysis showed a trend favoring the combination of RYBREVANT® and lazertinib compared to osimertinib* First pivotal study to show a clinically meaningful benefit in a chemotherapy-free regimen versus osimertinib  – See the […]